Who are the Main Recommenders of Herbal Drugs for Treating Neonatal Jaundice?

Message:
Article Type:
Research/Original Article (دارای رتبه معتبر)
Abstract:
Background

 The use of herbal drugs for treating neonatal jaundice is a common practice in many societies despite the potential complications. However, little is known about the individuals or groups who typically recommend the use of these drugs for affected neonates.

Objectives

 This study aims to investigate the main recommendations of herbal drugs for treating neonatal jaundice.

Methods

 The format of the present cross-sectional study was designed and implemented based on interviews with parents of infants who have infantile jaundice who used herbal drugs for their neonates during 2019 and 2022 and were admitted to the Children’s Medical Center of Tehran, Iran. Along with baseline data, the socioeconomic situation of families was also evaluated.

Results

 Regarding the role of people in recommending the use of herbal drugs, in 52.1% of cases, the main recommenders to use this substance to treat infant jaundice were the patient's relatives, while the role of parents in recommending the consumption of this compound was 25.5%. Also, 6.4% of the neighbors of the patients’ family were the main recommenders to use herbal drugs for the affected neonates. Interestingly, 4.3% of doctors and 11.7% of pharmacists had the leading role in recommending the use of herbal drugs to treat infant jaundice. Parents who recommended using herbal drugs for their neonates were more likely to be smokers and less affluent.

Conclusions

 Relatives, parents, grandparents, and even neighbors play a significant role in recommending the use of herbal drugs in the treatment and control of neonatal jaundice. The role of doctors and pharmacists in recommending the use of this compound in the treatment of jaundice, especially considering the potential side effects, should not be underestimated.

Language:
English
Published:
Journal of Comprehensive Pediatrics, Volume:15 Issue: 1, Feb 2024
Page:
12
https://magiran.com/p2669414  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!